NCT05591001

Brief Summary

The tethered spinal cord is a common pathology in pediatric neurosurgery. Intraoperative neurophysiologic monitoring (IOM) has gained popularity over the past two decades as a clinical discipline that uses neurophysiologic techniques to detect and prevent iatrogenic neurologic injuries. IOM techniques are extensively used in adult neurosurgery and, in their principles, can be applied to the pediatric population. Inhalational agents cause a dose-dependent reduction in MEPs and are arguably considered incompatible with effective neurophysiological monitoring(5) For this reason, total intravenous anesthesia (TIVA), using IV anesthetics (propofol or ketamine) and opioids (fentanyl or remifentanil), is commonly used in spinal surgeries under MEPs monitoring

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Oct 2022

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 21, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

October 30, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2023

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2023

Completed
Last Updated

February 7, 2024

Status Verified

February 1, 2024

Enrollment Period

5 months

First QC Date

October 17, 2022

Last Update Submit

February 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • the mean microvolts of 3 measurements of MEPs at 5 minutes interval at AH muscle before skin incision.

    the amplitude of motor evoked potentials measures

    2 hours

Secondary Outcomes (6)

  • fentanyl consumption in micrograms

    2 hours

  • Measurement of MEP at baseline once the patient will be prone , at surgical incision , and once exposure of the spine will be complete and during spinal manipulation and At the end of the surgery.

    2 hours

  • Measurements of blood pressure at base line T1, induction (T2) positioning( T3), skin incision (T4) , during spinal manipulation (T5)and by the end of the surgery (T6).

    2 hours

  • First rescue of analgesia

    2 hours

  • Side effects (sedation -hypotension ( MAP less than 25% from the baseline reading) - bradycardia - respiratory depression)

    6 hours

  • +1 more secondary outcomes

Study Arms (2)

Ketamine-dexmedetomidine group

ACTIVE COMPARATOR

Dexmedetomidine( 0.4 -0.6 μg/.kg /.h r)) ketamine,( 1-2m/.kg/.hr) infusion and giving bolus of fentanyl,( 1-2μg/.kg/ ) with keeping mean arterial blood pressure and heart rates changes within 25% of the baseline.

Drug: ketamine and dexmeditomidine combination

propofol group

ACTIVE COMPARATOR

propofol (100 ug/kg/min) -giving a bolus of fentanyl, (1-2μg/.kg/ ) with keeping mean arterial blood pressure and heart rate changes within 25% of the baseline.

Drug: Propofol

Interventions

Dexmedetomidine( 0.4 -0.6 μg/.kg /.hr)) ketamine,( 1 -2m/.kg/.hr) infusion

Ketamine-dexmedetomidine group

propofol (100 ug /kg/min) infusion

propofol group

Eligibility Criteria

Age3 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • children with ASA I and II presented to Abu elreesh hospital for untethered spinal cord surgery.

You may not qualify if:

  • Children with neuromuscular diseases or congenital scoliosis.
  • Children with growing rod distraction surgery.
  • Children with American Society of Anaesthesiologists (ASA) physical status III, IV
  • Children with preoperative use of antidepressant or anticonvulsant medications.
  • Children with a known history of drug allergies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amany Hassan Saleh

Giza, 02, Egypt

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Interventions

KetaminePropofol

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPhenolsBenzene DerivativesHydrocarbons, Aromatic

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
. The details of the series will be unknown to the investigators and the group assignment will be kept in a set of sealed envelopes, each bearing only the case number on the outside. a person who will prepare the drugs and data collector is not one of the trial investigators.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: forty six Children undergoing untethered spinal cord surgery will be randomly allocated into two equal groups using computerized generated random tables.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor of anesthesia ,surgical intensive care and pain management ,Cairo University

Study Record Dates

First Submitted

October 17, 2022

First Posted

October 21, 2022

Study Start

October 30, 2022

Primary Completion

March 20, 2023

Study Completion

April 10, 2023

Last Updated

February 7, 2024

Record last verified: 2024-02

Locations